These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Augmentation of diastolic function with phosphodiesterase inhibition in congestive heart failure. Binkley PF, Shaffer PB, Ryan JM, Leier CV. J Lab Clin Med; 1989 Sep; 114(3):266-71. PubMed ID: 2527935 [Abstract] [Full Text] [Related]
33. Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment. Dubourg O, Delorme G, Hardy A, Beauchet A, Tarral A, Bourdarias JP. Int J Cardiol; 1990 Jul; 28 Suppl 1():S33-42; discussion S43. PubMed ID: 2145237 [Abstract] [Full Text] [Related]
34. [Enoximone and the therapeutic strategy in patients awaiting emergency cardiac graft]. Dubois-Randé JL, Loisance D, Duval-Moulin AM, Deleuze P, Lellouche D, Tavolaro O, Hittinger L, Benvenuti C, Merlet P, Brun D. Arch Mal Coeur Vaiss; 1989 Jul; 82(8):1433-8. PubMed ID: 2529834 [Abstract] [Full Text] [Related]
35. [Enoximone as an alternative to mechanical circulatory support prior to heart transplantation]. Schmid ER, Zollinger A, Turina M, Dieterich HA. Schweiz Med Wochenschr; 1989 Sep 09; 119(36):1231-6. PubMed ID: 2529633 [Abstract] [Full Text] [Related]
37. Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure. Choraria SK, Taylor D, Pilcher J. Circulation; 1987 Dec 09; 76(6):1307-11. PubMed ID: 2960473 [Abstract] [Full Text] [Related]